Low-density lipoprotein particle number and risk for cardiovascular disease

Area of Science:

• Cardiovascular Medicine
• Lipid Metabolism
• Atherosclerosis Research

Background:

• Low-density lipoprotein (LDL) particles are crucial in coronary heart disease (CHD) pathogenesis.
• Lowering LDL cholesterol benefits high-risk patients, but optimal measurement for therapy identification is debated.
• Small LDL particles (pattern B) are associated with higher CHD risk at a given LDL cholesterol level.

Purpose of the Study:

• To evaluate whether LDL particle size or LDL particle number is a better predictor of CHD risk.
• To clarify the independent role of small LDL particles in atherosclerosis.
• To assess the clinical utility of different LDL measures in identifying individuals who would benefit from lipid-lowering therapy.

Main Methods:

• Review of studies comparing LDL particle size and LDL particle number as predictors of CHD.
• Analysis of the relationship between LDL particle phenotype (size) and atherogenicity.
• Examination of multivariate analyses assessing the independent association of LDL measures with CHD risk.

Main Results:

• Small LDL particles may not be inherently more atherogenic; higher particle numbers at a given LDL cholesterol level could explain increased risk.
• The small LDL particle phenotype often co-occurs with other metabolic risk factors like high triglycerides and low HDL cholesterol.
• LDL particle number, measured by nuclear magnetic resonance, is consistently identified as a strong, independent predictor of CHD.

Conclusions:

• LDL particle number is a more robust predictor of coronary heart disease risk than LDL particle size.
• Current LDL cholesterol measures may not fully identify all individuals who could benefit from therapy.
• Focusing on LDL particle number may improve risk stratification and guide therapeutic decisions in cardiovascular disease prevention.